General MedicationsINJECTIONStandard
INDIUM IN 111 OXYQUINOLINE
INDIUM IN-111 OXYQUINOLINE
Standard Dose
1mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview INDIUM IN 111 OXYQUINOLINE is listed in Drugs@FDA under application 019044 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient INDIUM IN-111 OXYQUINOLINE Form and strength INJECTABLE;INJECTION - 1mCi/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 2022-12-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview INDIUM IN 111 OXYQUINOLINE is listed in Drugs@FDA under application 019044 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient INDIUM IN-111 OXYQUINOLINE Form and strength INJECTABLE;INJECTION - 1mCi/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 2022-12-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.